申请人:Baxter Douglas Andrew
公开号:US20060019940A1
公开(公告)日:2006-01-26
Compounds of the general formula (1), wherein one of W, X, Y and Z is N or CR
4
and the others are each CH; and R
4
is a specified substituent. These compounds inhibit monocamine reuptake, and are useful in the treatment of pain, emesis depression, post traumatic stress disorders, attention deficit disorders, obsessive compulsive disorders, pre-menstrual syndrome, substance abuse and sexual dysfunction.
通式(1)的化合物中,其中W、X、Y和Z中的一个是N或CR4,其他的都是CH;而R4是一个指定的取代基。这些化合物抑制单胺再摄取,可用于治疗疼痛、呕吐、抑郁、创伤后应激障碍、注意力缺陷障碍、强迫症、经前综合症、物质滥用和性功能障碍。